Scam, kidnap by South African police

Scam, kidnap by South African police

Medical Writing Institute click here

MJoTAtalks click here

Emerald Pademelon Press LLC click here


Peace Scientists click here

Dr Susanna loves the countries and the peoples of Africa

Scam, kidnap by South African police

Scam, kidnap by South African police

 
Bookmark and Share
Don't get diabetes! Take care of yourself if you have it! Diabetes resources, click here.
Diabetes News
Clinical trials testing therapies for diabetes

Latest Top (15) News


A Safety and Efficacy Study of FCR001 vs Standard of Care in de Novo Living Donor Kidney Transplantation
Condition:   Transplanted Organ Rejection
Intervention:   Biological: FCR001
Sponsor:   Talaris Therapeutics Inc.
Not yet recruiting

Mon, 24 Jun 2019 12:00:00 EDT


Clozapine Induced Weight Gain
Conditions:   Weight Gain;   Antipsychotic Agents;   Pharmacogenetics
Intervention:   Other: No study intervention - observational study
Sponsor:   Cwm Taf University Health Board (NHS)
Not yet recruiting

Mon, 24 Jun 2019 12:00:00 EDT


Individualized Carbohydrate Intake Strategy to Improve Blood Glucose Control
Condition:   Type 1 Diabetes
Interventions:   Other: Physical activity;   Other: FreeStyle Libre;   Other: SenseWear Armband
Sponsor:   Institut de Recherches Cliniques de Montreal
Not yet recruiting

Mon, 24 Jun 2019 12:00:00 EDT


Living Green and Healthy for Teens RCT
Conditions:   Healthy Lifestyle;   Adolescent Behavior
Interventions:   Behavioral: Aim2Be smartphone app system;   Behavioral: BnLt smartphone app
Sponsors:   Population Health Research Institute;   Childhood Obesity Foundation;   University of British Columbia;   Ayogo Health Inc.;   Canadian Institutes of Health Research (CIHR)
Not yet recruiting

Mon, 24 Jun 2019 12:00:00 EDT


Research of Burden of Interstititial Lung Diseases in Turkey
Conditions:   Lung Diseases, Interstitial;   Fibrosis Lung
Intervention:  
Sponsor:   Karadeniz Technical University
Active, not recruiting

Mon, 24 Jun 2019 12:00:00 EDT


Vaccination Efficacy With Metformin in Older Adults
Conditions:   Aging;   Age-Related Immunodeficiency;   Vaccine Response Impaired
Interventions:   Drug: Metformin Hydrochloride Extended-Release Tablets;   Biological: Influenza Vaccine
Sponsor:   UConn Health
Recruiting

Mon, 24 Jun 2019 12:00:00 EDT


Effect of an Anti-inflammatory Diet on Patients With Cervical Cancer
Conditions:   Cervical Cancer;   Uterine Cervical Neoplasm;   Pelvic Inflammatory Disease;   Radiation Toxicity;   Diet Modification
Interventions:   Other: Omega-3 fatty acids;   Other: Antioxidants;   Other: Soluble fiber;   Other: Probiotics;   Other: Lactose restriction;   Other: Fiber restriction;   Other: Fat restriction
Sponsor:   National Institute of Cancerología
Recruiting

Fri, 21 Jun 2019 12:00:00 EDT


Effectiveness of a Transition Program for Adolescents With Type 1 Diabetes in the Transition to Adulthood
Condition:   Type 1 Diabetes
Interventions:   Behavioral: A Person-Centred Transition Program to Empower Adolescents With Type 1 Diabetes in the Transition to Adulthood: the STEPSTONES-DIAB Project;   Other: Standard care
Sponsors:   Göteborg University;   Karolinska University Hospital;   Swedish Child Diabetes Foundation;   Swedish Diabetes Foundation;   Gothenburg Centre for Person-Centred Care;   The Swedish Research Council;   Swedish Research Council for Health, Working Life and Welfare (FORTE)
Not yet recruiting

Fri, 21 Jun 2019 12:00:00 EDT


Effects of Empowerment-based Program on Post-discharge Glycemic Control, and Foot Ulcer
Condition:   Diabetic Foot Ulcer
Intervention:   Behavioral: individual empowerment-based intervention
Sponsor:   Chin yenfan
Not yet recruiting

Fri, 21 Jun 2019 12:00:00 EDT


Motor-assisted Cycling and FES Cycling for Postprandial Glucose in Diabetic Patients With ADL Disability
Conditions:   Type2 Diabetes;   Disability Physical
Interventions:   Behavioral: Motor-assisted cycling;   Behavioral: FES cycling
Sponsor:   Arizona State University
Recruiting

Fri, 21 Jun 2019 12:00:00 EDT


Optimizing Gait Rehabilitation for Veterans With Non-traumatic Lower Limb Amputation
Conditions:   Transtibial Amputation;   Peripheral Artery Disease;   Diabetes Mellitus
Interventions:   Behavioral: Error-augmentation gait training;   Behavioral: Error-correction gait training;   Behavioral: Supervised walking
Sponsor:   VA Office of Research and Development
Not yet recruiting

Fri, 21 Jun 2019 12:00:00 EDT


The Postprandial Effects of Chick-Pea Consumption on Glucose, Insulin, and Gut Hormone Responses (PEA-POD).
Condition:   Postprandial Period
Intervention:   Dietary Supplement: Chickpea powder
Sponsors:   King's College London;   Quadram Institute Bioscience;   New-Food Innovation;   Biotechnology and Biological Sciences Research Council
Recruiting

Fri, 21 Jun 2019 12:00:00 EDT


The Wound Infection After Stomy Closure Between Different Methods of Drainage
Condition:   Wound Infection
Intervention:   Procedure: J-P drainage and cutaneous penrose drainage insertion
Sponsor:   Taipei Medical University Shuang Ho Hospital
Not yet recruiting

Fri, 21 Jun 2019 12:00:00 EDT


A Study Using Medical Records of Danish People With Type 2 Diabetes Comparing Empagliflozin and Liraglutide in the Occurrence of Serious Cardiovascular Disease
Condition:   Diabetes Mellitus, Type 2
Interventions:   Drug: Empagliflozin;   Drug: Liraglutide
Sponsor:   Boehringer Ingelheim
Completed

Thu, 20 Jun 2019 12:00:00 EDT


Effect of Eating Within a Limited Time on Sugar Sensitivity and Liver Sugar Stores of People With Type 2 Diabetes.
Condition:   Type 2 Diabetes Mellitus
Intervention:   Behavioral: Time restricted feeding
Sponsors:   Maastricht University;   ZonMw: The Netherlands Organisation for Health Research and Development
Recruiting

Thu, 20 Jun 2019 12:00:00 EDT
FDA (Food and Drug Administration) press releases. FDA makes sure of the safety of all medicines which can be injected, breathed in, rubbed in and swallowed, in the United States of America.

Latest Top (10) News


FDA Statement on the FDA’s ongoing investigation into valsartan and ARB class impurities and the agency’s steps to address the root causes of the safety issues
FDA describes the ongoing investigation into the ARB class impurities and agency’s steps to address the root causes of the safety issues




FDA approves first anticoagulant (blood thinner) for pediatric patients to treat potentially life-threatening blood clots
The FDA approved Fragmin (dalteparin sodium) injection, for subcutaneous use, to reduce the recurrence of symptomatic venous thromboembolism (VTE) in pediatric patients one month of age and older.




FDA approves first chemoimmunotherapy regimen for patients with relapsed or refractory diffuse large B-cell lymphoma
FDA approved Polivy in combination with the chemotherapy bendamustine and a rituximab product to treat adult patients with diffuse large B-cell lymphoma that has progressed or returned after at least two prior therapies.




FDA approves new treatment for hypoactive sexual desire disorder in premenopausal women
FDA approved Vyleesi (bremelanotide) to treat acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women.




FDA approves new treatment for pediatric patients with type 2 diabetes
: FDA approves Victoza (liraglutide) injection for pediatric patients with type 2 diabetes. Victoza creates the same effect as GLP-1 receptor protein and is the first non-insulin drug approved since metformin in 2000.




FDA authorizes first interoperable insulin pump intended to allow patients to customize treatment through their individual diabetes management devices
FDA authorizes first interoperable insulin pump intended to allow patients to customize treatment through their individual diabetes management devices




FDA expands approval of treatment for cystic fibrosis to include patients ages 6 and older
FDA expanded the indication for Symdeko for treatment of pediatric patients ages 6 years and older with cystic fibrosis who have certain genetic mutations.




FDA finalizes guidance for premarket tobacco product applications for electronic nicotine delivery systems as part of commitment to continuing a strong oversight of e-cigarettes
FDA finalizes guidance for manufacturers submitting premarket tobacco product applications for electronic nicotine delivery systems, such as e-cigarettes or “vapes.”




FDA permits marketing of first medical device for relief of pain associated with irritable bowel syndrome in patients 11-18 years of age
FDA permits marketing of the first medical device to aid in the reduction of functional abdominal pain in patients 11-18 years of age with irritable bowel syndrome (IBS) when combined with other therapies for IBS.




FDA, FTC take action to protect kids by citing four firms that make, sell flavored e-liquids for violations related to online posts by social media influencers on their behalf
FDA and FTC cite four firms that make or sell several flavored e-liquid products for violations related to online posts by social media influencers on each company’s behalf.


Diabetes news from the American Diabetes Association

Latest Top (5) News